Precancerous condition

Mar 30, 2020

INOVIO Interim Results of an Open-Label Phase 2 Trial of VGX-3100 Show Efficacy Against HPV-associated Vulvar Dysplasia

Aug 19, 2019

Inovio Completes Enrollment of its VGX-3100 Open-label Phase 2 Trial for Treatment of HPV-Related High-Grade Anal Dysplasia

May 16, 2019

Check-Cap to Present Data at Digestive Disease Week® Demonstrating Substantial Improvement in Precancerous Polyp Detection

May 06, 2019

Inovio Receives European Medicines Agency Certification For Quality and Non-Clinical Data for Its Phase 3 Product, VGX-3100

Aug 22, 2018

Paragon Biosciences Announces Skyline Biosciences as the Newest Addition to Its Growing Portfolio of Companies

Jul 26, 2018

CureCervicalCancer Nearing Major Milestone of 100,000 Women Screened for Cervical Cancer

Jul 23, 2018

Dermtreat Announces First Patient Dosed in Phase 2b Clinical Trial of Rivelin Clobetasol for Oral Lichen Planus

Jul 10, 2018

Antiva Biosciences Closes $15 Million Series C-1 Financing

Apr 17, 2018

Pioneering Clinical Practice Live Implementation Proves Effectiveness of Medial EarlySign's AI-Based Tool to Identify Patients at High Risk of Having Colorectal Cancer

Apr 10, 2018

Proteocyte AI Leverages Proscia Digital Pathology Platform to Predict Risk of Oral Cancer

Sep 12, 2017

Cernostics Announces Leadership Team Expansion